These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31648648)

  • 21. Cap binding and immune evasion revealed by Lassa nucleoprotein structure.
    Qi X; Lan S; Wang W; Schelde LM; Dong H; Wallat GD; Ly H; Liang Y; Dong C
    Nature; 2010 Dec; 468(7325):779-83. PubMed ID: 21085117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G.
    Gabriel M; Adomeh DI; Ehimuan J; Oyakhilome J; Omomoh EO; Ighodalo Y; Olokor T; Bonney K; Pahlmann M; Emmerich P; Lelke M; Brunotte L; Ölschläger S; Thomé-Bolduan C; Becker-Ziaja B; Busch C; Odia I; Ogbaini-Emovon E; Okokhere PO; Okogbenin SA; Akpede GO; Schmitz H; Asogun DA; Günther S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006361. PubMed ID: 29596412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current molecular epidemiology of Lassa virus in Nigeria.
    Ehichioya DU; Hass M; Becker-Ziaja B; Ehimuan J; Asogun DA; Fichet-Calvet E; Kleinsteuber K; Lelke M; ter Meulen J; Akpede GO; Omilabu SA; Günther S; Olschläger S
    J Clin Microbiol; 2011 Mar; 49(3):1157-61. PubMed ID: 21191050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression.
    Jiang X; Huang Q; Wang W; Dong H; Ly H; Liang Y; Dong C
    J Biol Chem; 2013 Jun; 288(23):16949-16959. PubMed ID: 23615902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.
    Goba A; Khan SH; Fonnie M; Fullah M; Moigboi A; Kovoma A; Sinnah V; Yoko N; Rogers H; Safai S; Momoh M; Koroma V; Kamara FK; Konowu E; Yillah M; French I; Mustapha I; Kanneh F; Foday M; McCarthy H; Kallon T; Kallon M; Naiebu J; Sellu J; Jalloh AA; Gbakie M; Kanneh L; Massaly JL; Kargbo D; Kargbo B; Vandi M; Gbetuwa M; Gevao SM; Sandi JD; Jalloh SC; Grant DS; Blyden SO; Crozier I; Schieffelin JS; McLellan SL; Jacob ST; Boisen ML; Hartnett JN; Cross RW; Branco LM; Andersen KG; Yozwiak NL; Gire SK; Tariyal R; Park DJ; Haislip AM; Bishop CM; Melnik LI; Gallaher WR; Wimley WC; He J; Shaffer JG; Sullivan BM; Grillo S; Oman S; Garry CE; Edwards DR; McCormick SJ; Elliott DH; Rouelle JA; Kannadka CB; Reyna AA; Bradley BT; Yu H; Yenni RE; Hastie KM; Geisbert JB; Kulakosky PC; Wilson RB; Oldstone MB; Pitts KR; Henderson LA; Robinson JE; Geisbert TW; Saphire EO; Happi CT; Asogun DA; Sabeti PC; Garry RF;
    J Infect Dis; 2016 Oct; 214(suppl 3):S110-S121. PubMed ID: 27402779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding.
    Hastie KM; Liu T; Li S; King LB; Ngo N; Zandonatti MA; Woods VL; de la Torre JC; Saphire EO
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19365-70. PubMed ID: 22084115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA.
    Auperin DD; Sasso DR; McCormick JB
    Virology; 1986 Oct; 154(1):155-67. PubMed ID: 3750844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.
    Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H
    PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lassa fever diagnostics: past, present, and future.
    Happi AN; Happi CT; Schoepp RJ
    Curr Opin Virol; 2019 Aug; 37():132-138. PubMed ID: 31518896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
    Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection.
    Trappier SG; Conaty AL; Farrar BB; Auperin DD; McCormick JB; Fisher-Hoch SP
    Am J Trop Med Hyg; 1993 Aug; 49(2):214-21. PubMed ID: 8357084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory diagnosis of Lassa fever, liberia.
    Panning M; Emmerich P; Olschläger S; Bojenko S; Koivogui L; Marx A; Lugala PC; Günther S; Bausch DG; Drosten C
    Emerg Infect Dis; 2010 Jun; 16(6):1041-3. PubMed ID: 20507774
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction.
    Lunkenheimer K; Hufert FT; Schmitz H
    J Clin Microbiol; 1990 Dec; 28(12):2689-92. PubMed ID: 2279999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Mechanism for LAMP1 Recognition by Lassa Virus.
    Cohen-Dvashi H; Cohen N; Israeli H; Diskin R
    J Virol; 2015 Aug; 89(15):7584-92. PubMed ID: 25972533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018.
    Siddle KJ; Eromon P; Barnes KG; Mehta S; Oguzie JU; Odia I; Schaffner SF; Winnicki SM; Shah RR; Qu J; Wohl S; Brehio P; Iruolagbe C; Aiyepada J; Uyigue E; Akhilomen P; Okonofua G; Ye S; Kayode T; Ajogbasile F; Uwanibe J; Gaye A; Momoh M; Chak B; Kotliar D; Carter A; Gladden-Young A; Freije CA; Omoregie O; Osiemi B; Muoebonam EB; Airende M; Enigbe R; Ebo B; Nosamiefan I; Oluniyi P; Nekoui M; Ogbaini-Emovon E; Garry RF; Andersen KG; Park DJ; Yozwiak NL; Akpede G; Ihekweazu C; Tomori O; Okogbenin S; Folarin OA; Okokhere PO; MacInnis BL; Sabeti PC; Happi CT
    N Engl J Med; 2018 Nov; 379(18):1745-1753. PubMed ID: 30332564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population structure of Lassa Mammarenavirus in West Africa.
    Forni D; Sironi M
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32294960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response.
    Ortiz-Riaño E; Cheng BY; de la Torre JC; Martínez-Sobrido L
    J Virol; 2011 Dec; 85(24):13038-48. PubMed ID: 21976642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lassa virus circulating in Liberia: a retrospective genomic characterisation.
    Wiley MR; Fakoli L; Letizia AG; Welch SR; Ladner JT; Prieto K; Reyes D; Espy N; Chitty JA; Pratt CB; Di Paola N; Taweh F; Williams D; Saindon J; Davis WG; Patel K; Holland M; Negrón D; Ströher U; Nichol ST; Sozhamannan S; Rollin PE; Dogba J; Nyenswah T; Bolay F; Albariño CG; Fallah M; Palacios G
    Lancet Infect Dis; 2019 Dec; 19(12):1371-1378. PubMed ID: 31588039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa fever, Nigeria, 2005-2008.
    Ehichioya DU; Hass M; Olschläger S; Becker-Ziaja B; Onyebuchi Chukwu CO; Coker J; Nasidi A; Ogugua OO; Günther S; Omilabu SA
    Emerg Infect Dis; 2010 Jun; 16(6):1040-1. PubMed ID: 20507773
    [No Abstract]   [Full Text] [Related]  

  • 40. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
    Raabe VN; Kann G; Ribner BS; Morales A; Varkey JB; Mehta AK; Lyon GM; Vanairsdale S; Faber K; Becker S; Eickmann M; Strecker T; Brown S; Patel K; De Leuw P; Schuettfort G; Stephan C; Rabenau H; Klena JD; Rollin PE; McElroy A; Ströher U; Nichol S; Kraft CS; Wolf T;
    Clin Infect Dis; 2017 Sep; 65(5):855-859. PubMed ID: 29017278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.